A growing body of research shows that (Zhang Xin et al., 2020), lncRNA-NEAT1 is upregulated in immune-related disease, and facilitates the activation of the interferon (IFN) pathway by releasing a B-cell activating factor, thereby contributing to the incidence of SLE. Here, IFNA1 is linked to systemic lupus erythematosus.